Respiration_Advanced
July 29, 2026
1 min readIP Score 10/10
Artificial Intelligence in Interventional Pulmonology
Abstract
Abstract Background: Artificial intelligence (AI) has revolutionized interventional pulmonology (IP) by enhancing diagnostic accuracy, procedural efficiency, and training standardization. This review synthesizes current advancements and applications of AI across four key domains: education, imaging, navigation, and robotic bronchoscopy systems (RBS). Summary: In education, AI-powered convolutional neural networks (CNNs) improve airway structure recognition with an accuracy of 94.7%, thereby reducing learning curves and minimizing diagnostic errors. For imaging, deep learning models achieve lesion identification accuracy comparable to that of senior physicians (area under the curve: 0.940–0.981), enabling real-time intra-procedural guidance. Navigation technologies, such as virtual bronchoscopic navigation (VBN) and electromagnetic navigation bronchoscopy (ENB), enhance accessibility to peripheral lesions, achieving diagnostic yields of 77.9%–94.4% with excellent safety. RBS integrate AI-driven navigation and real-time imaging, achieving biopsy success rates up to 98.8% and diagnostic yield over 90%, while minimizing pneumothorax risks. Despite these advancements, challenges remain in algorithm validation, data privacy, and ethical considerations. AI demonstrates transformative potential in standardizing bronchoscopy practices, expanding access to underserved regions, and advancing personalized treatments. Key Message: AI significantly enhances the diagnostic accuracy and procedural safety of IP across education, imaging, navigation, and robotic systems; despite ongoing challenges in algorithm validation, AI is propelling the field toward standardized practices and personalized medicine.
This case highlights the diagnostic and management challenges of refractory multisystem sarcoidosis progressing over a two-year period despite advanced biologic therapy.
Clinicians should note that the presence of targetable mutations in non-small cell lung cancer with malignant pleural disease is not associated with improved survival, based on the findings from this study.
Shape-sensing robotic-assisted bronchoscopy achieved a strict diagnostic yield of 70.2% with a low pneumothorax rate of 3.3%, demonstrating that earlier tissue diagnosis of very small pulmonary nodules is feasible and safe for clinical practice.
Up nextJournal of Thoracic DiseaseOct 30, 2026Read
This study introduces ultrasound-guided trans-cannula cryobiopsy of supraclavicular lymph nodes as a novel superficial lymph node approach for tissue acquisition in 10 consecutive patients, though specific numeric success or safety results were not provided in the abstract.
Active infection is not an absolute contraindication to endobronchial valve placement, but positive pressure ventilation significantly increases clinical failure odds with an aOR of 3.00 at P < 0.001.